Invest now
Global Health share price
Balanced risk
You have to be logged in to add this to Watchlist.- ₹1,455.00(1.03%)August 7, 2026 15:29:47 PM IST
- NSE
- BSE
- Vol : 562.11 K (NSE + BSE)Last 20 day avg : 263.29 K
Global Health is trading 1.03% upper at Rs 1,455.00 as compared to its last closing price. Global Health has been trading in the price range of 1,484.00 & 1,446.30. Global Health has given 21.74% in this year & 1.97% in the last 5 days. Global Health has TTM P/E ratio 63.47 as compared to the sector P/E of 29.51.There are 11 analysts who have initiated coverage on Global Health. There are 4 analysts who have given it a strong buy rating & 2 analysts have given it a buy rating. 1 analysts have given the stock a sell rating.The company posted a net profit of 158.73 Crores in its last quarter.Listed peers of Global Health include Apollo Hospitals Enterprise (1.90%), Max Healthcare Institute (-0.19%), Fortis Healthcare (2.67%).The Mutual Fund holding in Global Health was at 16.03% in 30 Jun 2026. The MF holding has increased from the last quarter. The FII holding in Global Health was at 9.46% in 30 Jun 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 08 Aug 2026, 12:54 AM IST
- BetaLow volatility0.53Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.30The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.03Annual dividends as a percentage of the stock price.
- P/BHigher than historical values9.79The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values69.84Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates overvaluation3.88The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Global Health News
Global Health Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise | 8,980.50 | 1.90 | 1,29,125.81 | 64.93 | 13.39 | 0.23 | 53.80 |
| Max Healthcare Institute | 1,073.00 | -0.19 | 1,04,432.24 | 71.47 | 9.87 | 0.18 | 27.71 |
| Fortis Healthcare | 960.00 | 2.67 | 72,475.99 | 67.89 | 7.27 | 0.10 | 29.68 |
| Aster DM Healthcare | 875.00 | 3.62 | 45,703.64 | 102.55 | 9.26 | 0.49 | 44.74 |
| Narayana Hrudayalaya | 1,899.00 | 0.81 | 38,865.89 | 48.07 | 9.08 | 0.22 | 121.59 |
Mutual Fund Ownership
View allGlobal Health Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-07-30 | Quarterly Results |
| 2026-05-14 | Audited Results & Final Dividend |
| 2026-02-04 | Quarterly Results |
| 2025-11-07 | Quarterly Results |
| 2025-08-07 | Quarterly Results |
About the company Global Health
- IndustryHealthcare Facilities
- ISININE474Q01031
- BSE Code543654
- NSE CodeMEDANTA
Global Health Limited (Medanta) is an India-based multi-specialty tertiary care provider in the North and East regions of India. Medanta delivers advanced, end-to-end healthcare in Delhi, Gurugram, Indore, Ranchi, Patna, and Lucknow through its network of approximately five hospitals. Medanta provides healthcare services in over 30 medical specialties and engages over 1,800 doctors. Its specialty treatments are in cardiac care, cancer care, neurosciences, orthopedics, renal care, liver transplants, oncology, bone marrow transplant, obstetrics and gynecology, chest surgery, lung transplant, pediatric care, ENT, head and neck surgery, and others. Its facilities and services include medicine delivery, lab tests & diagnostics, homecare services, health checkups, elder care, air ambulance, among others. Its subsidiaries include Global Health Patliputra Private Limited, Medanta Holdings Private Limited, and GHL Pharma & Diagnostic Private Limited.
Global Health Share Price FAQs
Global Health is trading at 1455.00 as on Fri Aug 07 2026 09:59:47. This is 1.03% upper as compared to its previous closing price of 1440.10.
The market capitalization of Global Health is 39120.85 Cr as on Fri Aug 07 2026 09:59:47.
The average broker rating on Global Health is Buy. The breakup of analyst rating is given below -
- 4 analysts have given a strong buy rating
- 2 analysts have given a buy rating
- 4 analysts have given a hold rating
- 1 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Global Health is 1475.75 whereas the 52 wk low is 955.20
Global Health can be analyzed on the following key metrics -
- TTM P/E: 63.47
- Sector P/E: 29.51
- Dividend Yield: 0.03%
- D/E ratio: -
Global Health reported a net profit of 556.46 Cr in 2026.
The Mutual Fund Shareholding was 16.03% at the end of 30 Jun 2026.
Quick Links
EQUITY QUICK LINKS
Global Health QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.